Autoantibodies against 'nuclear dots' in primary biliary cirrhosis

Seminars in Liver Disease

Volumn 17, Issue 1, 1997, Pages 71-78

  Szostecki, Carin ^a   Guldner, Hans H ^a   Will, Hans ^a,b  

^a UNIVERSITY OF HAMBURG   (Germany)

^b LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

Author keywords

autoantigens; autoimmunity; interferon; nuclear dots; PBC; PML; Sp100

Indexed keywords

AUTOANTIBODY;

ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIGENICITY; ARTICLE; AUTOIMMUNITY; CHOLESTASIS; COMPLEX FORMATION; HUMAN; IMMUNE RESPONSE; MOLECULAR CLONING; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0030965839     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1007184     Document Type: Article

References (74)

1. Berg PA, Klein R: Immunology of primary biliary cirrhosis. Baillière's Clin Gastroenterology 1:675-706, 1987.
2. Gershwin ME, Mackay IR: Primary biliary cirrhosis: Paradigm or paradox for autoimmunity. Gastroenterology 100:822-33, 1991.
3. Pape GR, Spengler U, Hoffmann RM, Jung CM: Pathogenesis of primary biliary cirrhosis: New aspects for a role of T-lymphocytes. In EL Krawitt, RH Wiesner (eds.): Autoimmune liver disease. New York, Raven Press, 1991, pp 43-62.
4. Sherlock S: Primary biliary cirrhosis. In: Sherlock S (ed): Diseases of the liver and biliary system. 8th ed. Oxford: Blackwell Scientific, 1977, pp 273-88.
5. Vierling JM: Primary biliary cirrhosis. In: Zakin D, Boyer TD (eds): Hepatology. A textbook of liver disease. 2nd ed. Philadelphia: WB Saunders, 1990, pp 1158-1205.
6. Lozano F, Parés A, Borche L, et al: Autoantibodies against nuclear envelope-associated proteins in primary biliary cirrhosis. Hepatology 8:930-8, 1988.
7. Lassoued K, Brenard R, Degos F, et al: Antinuclear antibodies directed to a 200-kilodalton polypeptide of the nuclear envelope in primary biliary cirrhosis Gastroenterology 99:181-6, 1990.
8. Courvalin JC, Lassoued K, Worman HJ, Blobel G: Identification and characterization of autoantibodies against the nuclear envelope lamin B receptor from patients with primary biliary cirrhosis. J Exp Med 172:961-7, 1990.
9. Nickowitz RE, Wozniak RW, Schaffner F, Worman HJ: Autoantibodies against integral membrane proteins of the nuclear envelope in patients with primary biliary cirrhosis. Gastroenterology 106:193-9, 1994.
10. Wesierska-Gadek J, Hohenauer H, Hitchman E, Penner E: Autoantibodies against nucleoporin p62 constitute a novel marker of primary biliary cirrhosis. Gastroenterology 110:840-7, 1996.
11. Bernstein RM, Neuberger JM, Bunn CC, et al: Diversity of autoantibodies in primary biliary cirrhosis and chronic active hepatitis. Clin Exp Immunol 55:553-60, 1984.
12. Fritzler MJ, Valencia DW, McCarty GA: Speckled pattern antinuclear antibodies resembling anticentromere antibodies. Arthritis Rheum 27:92-6, 1984.
13. Pisi E, Bianchi FB, Ballardini G, et al: New immunopathologic features in primary biliary cirrhosis. Front Gastrointest Res 9:132-42, 1986.
14. Powell FC, Schroeter AL, Dickson ER: Antinuclear antibodies in primary biliary cirrhosis. Lancet i:288-9, 1984.
15. Szostecki C, Krippner H, Penner E, Bautz FA: Autoimmune sera recognize a 100 kD nuclear protein antigen (Sp100). Clin Exp Immunol 68:108-16, 1987.
16. Szostecki C, Guldner HH, Netter HJ, Will H: Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis. J Immunol 145:4338-47, 1990.
17. Evans J, Reuben A, Craft J: PBC 95K, a 95-kilodalton nuclear autoantigen in primary biliary cirrhosis. Arthritis Rheum 34:731-6, 1991.
18. Fusconi M, Cassani F, Govoni M, et al: Anti-nuclear antibodies of primary biliary cirrhosis recognize 78-92 kD and 96-100 kD proteins of nuclear bodies. Clin Exp Immunol 83:291-7, 1991.
19. Raska I, Dundr M, Koberna K: Structure-function subcompartments of the mammalian cell nucleus as revealed by the electron microscopic affinity cytochemistry. Cell Biol Int Rep 16:771-89, 1992.
20. Sternsdorf T, Guldner HH, Szostecki C, et al: Two nuclear dot-associated proteins, PML and Sp100, are often co-autoimmunogenic in patients with primary biliary cirrhosis. Scand J Immunol 42:257-68, 1995.
21. Dyck JA, Maul GG, Miller WJ, et al: A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 76:333-43, 1994.
22. de Thé H, Chomienne C, Lanotte M, et al: The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor to a novel transcribed locus. Nature 347:558-61, 1990.
23. Koken MHM, Puvion-Dutilleul F, Guillemin MC, et al: The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO J 13:1073-83, 1994.
24. Korioth F, Gieffers C, Maul GG, Frey J: Molecular characterization of NDP52, a novel protein of the nuclear domain 10, which is redistributed upon virus infection and interferon treatment. J Cell Biol 130 1-13, 1995
25. Ascoli CA, Maul GG: Identification of a novel nuclear domain. J Cell Biol 112:785-95, 1991.
26. Lamond AI, Carmo-Fonseca M: The coiled body Trends Cell Biol 3:198-204, 1991.
27. Weis K, Rambaud S, Lavau C, et al: Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells. Cell 76:345-56, 1994.
28. de Thé G, Rivière M, Bernhard W: Examen au microscope électronique de la tumeur VX2 du lapin domestique dérivée du papillome de Shope. Bull Cancer 47:569-84, 1960.
29. Brasch K, Ochs RL: Nuclear bodies (NBs): A newly "rediscovered" organelle. Exp Cell Res 202:211-23, 1992.
30. Szostecki C: Studien zur Struktur, Expression und Funktion des nukleären Sp 100-Autoantigens und Analyse der humoralen Autoimmunantwort. Dissertation Ludwig-Maximilians-Universität München, Akademischer Verlag München, 1992.
31. Xie K, Lambie EJ, Snyder M: Nuclear dot antigens may specify transcriptional domains in the nucleus. Mol Cell Biol 13:6170-9, 1993.
32. Guldner HH, Szostecki C, Grötzinger T, Will H: IFN enhance expression of Sp 100, an autoantigen in primary biliary cirrhosis. J Immunol 149.4067-73, 1992.
33. Grötzinger T, Sternsdorf T, Jensen K, Will H: Interferon-modulaled expression of genes encoding the nuclear-dot-associated proteins Sp100 and promyelocytic leukemia protein (PML). Eur J Biochem 238:554-60, 1996.
34. Maul GG, Guldner HH, Spivack JG: Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product (ICPO). J Gen Virol 74:2679-90, 1993.
35. Maul GG, Everett RD: HSV-1 IE protein Vmw 110 causes redistribution of PML. EMBO J 13:5062-9, 1994.
36. 35a. Szekely L, Pokrovskaja K, Jiang WQ, et al: The Epstein-Barr virus-encoded nuclear antigen EBNA-5 accumulates in PML-containing bodies. J Virol 70:2562-8, 1996.
37. Kelly C, van Driel R, Wilkinson GWG: Disruption of PML-associated nuclear bodies during human cytomegalovirus infection. J Gen Virol 76:2887-93, 1995.
38. Carvalho T, Seeler JS, Öhman K, et al: Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies. J Cell Biol 131:45-56, 1995.
39. Puvion-Dutilleul F, Chelbe-Alix MK, Koken M, et al: Adenovirus infection induces rearrangements in the intranuclear distribution of the nuclear body-associated PML protein. Exp Cell Res 218:9-16, 1995.
40. Grötzinger T, Jensen K, Guldner HH, et al: A highly amplified mouse gene is homologous to the human interferon-responsive Sp100 gene encoding an autoantigen associated with nuclear dots. Mol Cell Biol 16:1150-6, 1996.
41. Plass C, Weichenhan D, Kunze B, et al: A member of the mouse LRR transcript family with homology to the human Sp100 gene. Hereditas 122:245-56, 1995.
42. Goddard AD, Borrow J, Freemont PS, Solomon E: Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. Science 254:1371-4, 1991.
43. Perez A, Kastner P, Sethi S, et al: PMLRAR homodimers: distinct DNA binding properties and heteromeric interactions with RXR. EMBO J 12:3171-82, 1993.
44. Le XF, Yang P, Chang KS: Analysis of the growth and transformation suppressor domains of promyelocytic leukemia gene, PML. J Biol Chem 271:130-5, 1996.
45. Mu ZM, Chin KV. Liu JH, et al: PML, a growth suppressor disrupted in acute promyelocytic leukemia. Mol Cell Biol 14: 6858-67, 1994.
46. Koken MHM, Linares-Cruz G, Quignon F, et al: The PML growth-suppressor has an altered expression in human oncogenesis. Oncogene 10:1315-24, 1995.
47. Terris B, Baldin V, Dubois S, et al. PML nuclear bodies are general targets for inflammation and cell proliferation. Cancer Res 55:1590-7, 1995.
48. Lavau C, Marchio A, Fagioli M, et al: The acute promyelocytic leukaemia-associated OML gene is induced by interferon. Oncogene 11:871-6, 1995.
49. Stadler M, Chelbi-Alix M, Koken MHM, et al: Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element. Oncogene 11:2565-73, 1995.
50. Grignani F, Ferrucci PF, Testa U, et al: The acute promyelocytic leukemia-specific PML-RARαfusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 74:423-31, 1993.
51. Rowley JD, Golomb HM, Dougherty C: 15/17 translocation, a consistent chromosomal change in acute promyelocytic leukemia. Lancet 1:549-50, 1977.
52. Kakizuka A, Miller WJ, Umesono K, et al: Chromosomal translocation t(15,17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML Cell 66:663-74, 1991.
53. de Thé H, Lavau C, Marchio A, et al: The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66:675-84, 1991.
54. Daniel MT, Koken M, Romagné O, et al: PML protein expression in hematopoietic and acute promyelocytic leukemia cells. Blood 82.1858-67, 1993.
55. Breitman TR, Collins SJ, Keene BR: Terminal differentiation of promyelocytic leucaemic cells in response to retinoic acid. Blood 57:1000-4, 1981.
56. Szostecki C, Will H, Guldner HH: Die humorale Autoimmunantwort gegen das nukleäre Sp100 Autoantigen in Patienten mit Primär biliärer Zirrhose. Z ärztl Fortbild 88:573-8, 1994.
57. Fregeau DR, Leung PSC, Coppel RL, et al: Autoantibodies to mitochondria in systemic sclerosis. Arthritis Rheum 31:386-92, 1988.
58. Klein R, Klöppel G, Garbe W, et al: Antimitochondrial antibody profiles determined at early stages of primary biliary cirrhosis differentiate between a benign and a progressive course of the disease. J Hepatology 12:21-27, 1991.
59. Michieletti P, Wanless IR, Katz A, et al: Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis. Gut 35:260-5, 1994.
60. Szostecki C, Will H, Netter HJ, Guldner HH: Autoantibodies to the nuclear Sp100 protein in primary biliary cirrhosis and associated diseases: Epitope specificity and immunoglobulin class distribution. Scand J Immunol 36:555-64, 1992.
61. Ishii H, Muno D, Namihisa T: Electrophoretic studies of anti-mitochondrial antibodies: Identification of mitochondrial antigens specific to primary biliary cirrhosis. Electrophoresis 10:612-6, 1989.
62. Mutimer DJ, Fussey SPM, Yeaman SJ, et al: Frequency of IgG and IgM autoantibodies to four specific M2 mitochondrial autoantigens in primary biliary cirrhosis. Hepatology 10:403-7, 1989
63. Hildebrandt S, Weiner E, Senécal JL, et al: The IgG, IgM and IgA isotypes of anti-topoisomerase I and anticentromere autoantibodies. Arthritis Rheum 33:724-7, 1990
64. 62a. Netter HJ, Will H, Szostecki C, Guldner HH: Repetitive p68-autoantigen specific epitopes recognized by human anti-(U1) small nuclear ribonucleoprotein autoantibodies. J Autoimmun 4:651-63, 1991.
65. Williams DG, Sharpe NG, Wallace G, Latchman DS: A repeated proline-rich sequence in Sm B/B'and N is a dominant epitope recognized by human and murine autoantibodies. J Autoimmunity 3:715-25, 1990.
66. McNeilage LJ, Macmillan EM, Whittingham SF: Mapping of epitopes on the La(SS-B) autoantigen of Primary Sjogren's syndrome: identification of a cross-reactive epitope. J Immunol 145.3829-35, 1990.
67. Gleichmann E, Pals ST, Rolink AG, et al: Graft-versus-host reactions: clues to the etiopathology of a spectrum of immunological diseases. Immunol Today 5:324-32, 1984.
68. Brendel V, Dohlman J, Blaisdell BE, Karlin S: Very long charge runs in systemic lupus erythematosus-associated autoantigens. Proc Natl Acad Sci USA 88:1536-40, 1991.
69. Dohlman JG, Lupas A, Carson M: Long charge-rich alpha-helices in systemic autoantigens. Biochem Biophys Res Commun 195:686-96, 1993.
70. Douvas A, Sobelman S: Multiple overlapping homologies between two rheumatoid antigens and immunosuppressive viruses. Proc Natl Acad Sci USA 88:6328-32, 1991.
71. Xie K, Snyder M: Two short autoepitopes on the nuclear dot antigen are similar to epitopes encoded by the Epstein-Barr virus. Proc Natl Acad Sci USA 92:1639-43, 1995.
72. Ballardini G, Mirakian R, Bianchi FB, et al: Aberrant expression of HLA-DR antigens on bile duct epithelium in primary biliary cirrhosis: relevance to pathogenesis. Lancet 2:1009-13, 1984.
73. Lobo-Yeo A, Senaldi G, Portmann B, et al: Class I and class II major histocompatibility complex antigen expression on hepatocytes: a study in children with liver disease. Hepatology 12-224-32, 1990.
74. Van den Oord JJ, Sciot P, Desmet VJ. Expression of MHC products by normal and abnormal bile duct epithelium. J Hepatol 3:310-17, 1986.